BCL2 and nasopharyngeal carcinoma: For example, miR-184 inhibits the proliferation and invasion of human glioma and breast cancer cells [12], and blocks the growth and survival of nasopharyngeal carcinoma cells by directly targeting BCL2 and C-MYC19 [31].